Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AUPHAUPH
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AURINIA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 5.6M shares of AUPH (AURINIA PHARMACEUTICALS INC), worth $95.4M as of 2026-Q2. The position was increased (+292.0% shares). AUPH represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$95.4M

Current Shares

5.6M

Total Value Change

+$79.6M

Total Shares Change

+3.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.6M
+292.0%
$95.4M0.0%$16.97
48
2026-Q1
Increased
1.4M
+42.5%
$21.2M0.0%$14.15
38
2025-Q4
Increased
1M
+19.5%
$16.1M0.0%$15.82
33
2025-Q3
Increased
842,027
+91.8%
$9.3M0.0%$11.06
44
2025-Q2
Decreased
439,020
-73.1%
$3.7M0.0%$8.64
0
2025-Q1
Decreased
1.6M
-6.9%
$13.1M0.0%$8.29
0
2024-Q4
New
1.8M
-
$15.7M0.0%$9.17
39

Other major holders of AUPH: SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used